Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves Roche’s Tecentriq combination to treat breast cancer

pharmaceutical-technologySeptember 03, 2019

Tag: EC , breast , Cancer , Roche , Tecentriq

PharmaSources Customer Service